Cargando…

Switches between biologics in patients with moderate‐to‐severe psoriasis: results from the French cohort PSOBIOTEQ

BACKGROUND: Biologics are the cornerstone of treatment of patients with moderate‐to‐severe plaque psoriasis and switches between biologics are frequently needed to maintain clinical improvement over time. OBJECTIVES: The main purpose of this study was to describe precisely switches between biologics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curmin, R., Guillo, S., De Rycke, Y., Bachelez, H., Beylot‐Barry, M., Beneton, N., Chosidow, O., Dupuy, A., Joly, P., Jullien, D., Richard, M.A., Viguier, M., Sbidian, E., Paul, C., Mahé, E., Tubach, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles and Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796114/ https://www.ncbi.nlm.nih.gov/pubmed/35793473 http://dx.doi.org/10.1111/jdv.18409

Ejemplares similares

Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort
por: Arlegui, H., et al.
Publicado: (2023)

Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort
por: BETTUZZI, Thomas, et al.
Publicado: (2022)

Impact de l’épidémie de COVID-19 lors de la 1(ère) vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané
por: Arlegui, Hugo, et al.
Publicado: (2021)

Impact of Childhood Onset Psoriasis on Addictive Behaviours, Socioeconomic and Educational Data in Adulthood
por: MAHÉ, Emmanuel, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on children with psoriasis
por: Beytout, Q., et al.
Publicado: (2021)

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
por: Assan, F., et al.
Publicado: (2022)

Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method
por: Richard, Marie-Aleth, et al.
Publicado: (2022)

Response to “New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019”
por: Assan, Florence, et al.
Publicado: (2021)

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Bertolotti, A., et al.
Publicado: (2021)

French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults
por: Amatore, F., et al.
Publicado: (2019)

Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
por: Gilet, H, et al.
Publicado: (2015)

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review
por: Gault, Nathalie, et al.
Publicado: (2017)

Pustular Psoriasis: The Dawn of a New Era
por: BACHELEZ, Hervé
Publicado: (2020)

Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Hacard, F., et al.
Publicado: (2021)

Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study
por: Zerah, Lorène, et al.
Publicado: (2021)

Choice of Systemic Drugs for the Management of Moderate-tosevere Psoriasis: A Cross-country Comparison Based on National Health Insurance Data
por: SBIDIAN, Emilie, et al.
Publicado: (2021)

Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System
por: Jourdain, Hugo, et al.
Publicado: (2023)

Is heat shock protein 90 inhibition a relevant treatment strategy for psoriasis?
por: Bachelez, Hervé
Publicado: (2022)

The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
por: Jullien, Denis, et al.
Publicado: (2023)

Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database
por: Seror, Raphaele, et al.
Publicado: (2022)

Correction to: The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
por: Jullien, Denis, et al.
Publicado: (2023)

Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trial
por: Beylot-Barry, Marie, et al.
Publicado: (2022)

Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study
por: Richard, M.‐A., et al.
Publicado: (2020)

Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study
por: Carlet, Clémentine, et al.
Publicado: (2020)

Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France
por: de Rycke, Yann, et al.
Publicado: (2020)

Psychological and professional impact of COVID-19 lockdown on French dermatologists: Data from a large survey
por: Misery, L., et al.
Publicado: (2021)

A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain
por: Puig, L., et al.
Publicado: (2017)

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
por: Zheng, Min, et al.
Publicado: (2022)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
por: Mahé, Emmanuel
Publicado: (2020)

Comments on ‘French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults’
por: Schuster, C., et al.
Publicado: (2019)

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
por: van de Kerkhof, P.C.M., et al.
Publicado: (2015)

Traitements du psoriasis et risque d’hospitalisation ou de décès pour COVID-19. Étude de cohorte à propos de 132 6312 patients atteints de psoriasis en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Psychometric validation of a patient-reported outcome questionnaire (Qualipsosex) assessing the impact of psoriasis and psoriatic arthritis on patient perception of sexuality
por: Lespessailles, Eric, et al.
Publicado: (2021)

TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
por: Jourdain, Hugo, et al.
Publicado: (2022)

COVID-19 et psoriasis chez l’enfant. Données d’une cohorte internationale
por: Zitouni, Jinane, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares
por: Choon, Siew Eng, et al.
Publicado: (2023)

A prescription support-tool for chronic management of oral antithrombotic combinations in adults based on a systematic review of international guidelines
por: Zerah, Lorene, et al.
Publicado: (2019)

On the use of propensity scores in case of rare exposure
por: Hajage, David, et al.
Publicado: (2016)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
por: Mahil, Satveer K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_35bvk2bmomjelh31i48hjuan46